Hancock Jaffe Laboratories Inc ROIC
¿Qué es el ROIC de Hancock Jaffe Laboratories Inc?
El ROIC de Hancock Jaffe Laboratories Inc es -130.76%
¿Cuál es la definición de ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC de compañías en Sector Health Care en NASDAQ en comparadas con Hancock Jaffe Laboratories Inc
¿Qué hace Hancock Jaffe Laboratories Inc?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Empresas con roic similar a Hancock Jaffe Laboratories Inc
- Alternate Health tiene ROIC de -131.22%
- Akari Therapeutics Plc tiene ROIC de -131.14%
- Ideanomics Inc tiene ROIC de -130.90%
- Claren tiene ROIC de -130.90%
- KWESST Micro Systems tiene ROIC de -130.86%
- KWESST Micro Systems tiene ROIC de -130.86%
- Hancock Jaffe Laboratories Inc tiene ROIC de -130.76%
- Tetra Bio-Pharma tiene ROIC de -130.74%
- Odyssey Semiconductor Technologies tiene ROIC de -130.61%
- G2 Technologies tiene ROIC de -130.35%
- T2 Biosystems Inc tiene ROIC de -129.43%
- Allena Pharmaceuticals Inc tiene ROIC de -129.33%
- Aurum Resources Ltd tiene ROIC de -128.63%